Artelo Biosciences Regains Compliance with Nasdaq Itemizing Necessities

Denali Therapeutics Regains Full Rights to Investigational Remedy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)